Shl Telemedicine (0QMX) Ratios
Shl Telemedicine Ratios
GB:0QMX's free cash flow for Q2 2026 was $-2.00M. For the 2026 fiscal year, GB:0QMX's free cash flow was decreased by $-513.69K and operating cash flow was $-1.49M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.25 | 1.04 | 2.30 | 1.81 | 2.64 |
| Quick Ratio | 1.20 | 0.99 | 2.10 | 1.59 | 2.40 |
| Cash Ratio | 0.87 | 0.29 | 0.38 | 0.25 | 0.85 |
| Solvency Ratio | -0.20 | -0.50 | 0.02 | 0.14 | -0.14 |
| Operating Cash Flow Ratio | -0.07 | -0.01 | -0.09 | -0.00 | 0.01 |
| Short-Term Operating Cash Flow Coverage | -0.74 | -0.17 | -0.69 | -0.03 | 0.10 |
| Net Current Asset Value | $ -4.60M | $ -14.04M | $ 3.47M | $ -19.21M | $ -22.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.20 | 0.18 | 0.24 | 0.25 |
| Debt-to-Equity Ratio | 0.30 | 0.41 | 0.27 | 0.48 | 0.57 |
| Debt-to-Capital Ratio | 0.23 | 0.29 | 0.21 | 0.32 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.17 | 0.12 | 0.19 | 0.23 |
| Financial Leverage Ratio | 1.93 | 2.06 | 1.54 | 1.99 | 2.28 |
| Debt Service Coverage Ratio | 0.62 | -5.74 | 0.62 | 2.46 | 1.67 |
| Interest Coverage Ratio | -3.82 | -23.88 | -6.95 | -4.18 | -0.94 |
| Debt to Market Cap | 0.29 | 0.18 | 0.08 | 0.05 | 0.06 |
| Interest Debt Per Share | 0.67 | 0.87 | 1.07 | 1.42 | 2.35 |
| Net Debt to EBITDA | -3.71 | -0.46 | 4.35 | 2.35 | 4.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.22% | 45.43% | 44.26% | 46.08% | 49.60% |
| EBIT Margin | -7.69% | -45.25% | -8.18% | 3.97% | 0.43% |
| EBITDA Margin | 5.34% | -31.97% | 5.30% | 16.07% | 8.77% |
| Operating Profit Margin | -7.69% | -47.19% | -15.78% | -8.76% | -1.00% |
| Pretax Profit Margin | -24.69% | -47.23% | -10.45% | 2.22% | -27.17% |
| Net Profit Margin | -26.20% | -49.48% | -12.36% | -0.13% | -28.46% |
| Continuous Operations Profit Margin | -26.20% | -48.88% | -12.01% | 0.36% | -28.08% |
| Net Income Per EBT | 106.11% | 104.78% | 118.31% | -5.79% | 104.76% |
| EBT Per EBIT | 321.26% | 100.08% | 66.22% | -25.40% | 2710.06% |
| Return on Assets (ROA) | -19.05% | -34.79% | -6.24% | -0.07% | -10.89% |
| Return on Equity (ROE) | -36.83% | -71.58% | -9.60% | -0.14% | -24.82% |
| Return on Capital Employed (ROCE) | -8.51% | -49.42% | -9.42% | -5.56% | -0.44% |
| Return on Invested Capital (ROIC) | -7.90% | -45.76% | -8.99% | -0.87% | -0.43% |
| Return on Tangible Assets | -30.96% | -61.17% | -10.12% | -0.13% | -19.79% |
| Earnings Yield | -50.50% | -49.79% | -4.33% | -0.02% | -4.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.86 | 7.48 | 6.67 | 6.42 | 5.50 |
| Payables Turnover | 8.26 | 8.49 | 8.19 | 8.47 | 8.66 |
| Inventory Turnover | 25.51 | 26.46 | 9.20 | 8.20 | 5.95 |
| Fixed Asset Turnover | 7.16 | 5.26 | 4.71 | 3.76 | 2.91 |
| Asset Turnover | 0.73 | 0.70 | 0.50 | 0.53 | 0.38 |
| Working Capital Turnover Ratio | 15.09 | 4.82 | 3.08 | 2.75 | 3.10 |
| Cash Conversion Cycle | 23.31 | 19.60 | 49.85 | 58.23 | 85.56 |
| Days of Sales Outstanding | 53.20 | 48.79 | 54.72 | 56.83 | 66.33 |
| Days of Inventory Outstanding | 14.31 | 13.79 | 39.68 | 44.51 | 61.38 |
| Days of Payables Outstanding | 44.20 | 42.98 | 44.56 | 43.11 | 42.14 |
| Operating Cycle | 67.51 | 62.58 | 94.41 | 101.34 | 127.70 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.09 | -0.02 | -0.08 | -0.00 | 0.01 |
| Free Cash Flow Per Share | -0.16 | -0.20 | -0.35 | -0.09 | -0.22 |
| Dividend Paid and CapEx Coverage Ratio | -1.21 | -0.10 | -0.27 | -0.04 | 0.06 |
| Capital Expenditure Coverage Ratio | -1.21 | -0.10 | -0.27 | -0.04 | 0.06 |
| Operating Cash Flow Coverage Ratio | -0.15 | -0.02 | -0.08 | -0.00 | 0.01 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.01 | -0.03 | -0.00 | 0.00 |
| Free Cash Flow Yield | -10.91% | -7.15% | -4.29% | -0.55% | -1.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.96 | -1.67 | -23.09 | -4150.49 | -20.84 |
| Price-to-Sales (P/S) Ratio | 0.52 | 0.99 | 2.85 | 5.35 | 5.93 |
| Price-to-Book (P/B) Ratio | 0.73 | 1.44 | 2.22 | 5.66 | 5.17 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.17 | -13.98 | -23.31 | -181.91 | -95.69 |
| Price-to-Operating Cash Flow Ratio | -16.75 | -151.67 | -108.90 | -4321.06 | 1589.51 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.01 | -0.00 | 41.71 | 0.01 |
| Enterprise Value Multiple | 6.01 | -3.57 | 58.23 | 35.63 | 71.66 |
| Enterprise Value | 19.73M | 64.86M | 176.07M | 337.70M | 311.72M |
| EV to EBITDA | 6.01 | -3.57 | 58.23 | 35.63 | 71.66 |
| EV to Sales | 0.32 | 1.14 | 3.08 | 5.72 | 6.29 |
| EV to Free Cash Flow | -5.67 | -16.07 | -25.20 | -194.75 | -101.44 |
| EV to Operating Cash Flow | -10.36 | -174.36 | -117.70 | -4625.97 | 1684.95 |
| Tangible Book Value Per Share | 0.52 | 0.22 | 1.68 | 0.26 | 0.18 |
| Shareholders’ Equity Per Share | 2.04 | 1.99 | 3.73 | 2.83 | 4.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.06 | -0.04 | -0.15 | 0.84 | -0.03 |
| Revenue Per Share | 2.87 | 2.88 | 2.90 | 2.99 | 3.53 |
| Net Income Per Share | -0.75 | -1.43 | -0.36 | -0.00 | -1.00 |
| Tax Burden | 1.06 | 1.05 | 1.18 | -0.06 | 1.05 |
| Interest Burden | 3.21 | 1.04 | 1.28 | 0.56 | -63.83 |
| Research & Development to Revenue | 0.05 | 0.09 | 0.09 | 0.06 | -0.01 |
| SG&A to Revenue | 0.18 | 0.42 | 0.36 | 0.35 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 |
| Income Quality | 0.12 | 0.01 | 0.22 | 0.96 | -0.01 |
Currency in USD